Published in IUBMB Life on October 01, 2004
Evaluation of alternatives to warfarin as probes for Sudlow site I of human serum albumin: characterization by high-performance affinity chromatography. J Chromatogr A (2008) 1.08
Targeting anti-HIV drugs to the CNS. Expert Opin Drug Deliv (2009) 1.05
Human serum albumin inhibits Abeta fibrillization through a "monomer-competitor" mechanism. Biophys J (2009) 1.05
The male genital tract is not a pharmacological sanctuary from efavirenz. Clin Pharmacol Ther (2011) 0.89
Ibuprofen impairs allosterically peroxynitrite isomerization by ferric human serum heme-albumin. J Biol Chem (2009) 0.86
The design and delivery of a thermally responsive peptide to inhibit S100B-mediated neurodegeneration. Neuroscience (2011) 0.82
Isoniazid and rifampicin inhibit allosterically heme binding to albumin and peroxynitrite isomerization by heme-albumin. J Biol Inorg Chem (2010) 0.79
Molecular fluorescence, phosphorescence, and chemiluminescence spectrometry. Anal Chem (2006) 0.78
An albumin-derived peptide scaffold capable of binding and catalysis. PLoS One (2013) 0.77
Binding Interactions of Keratin-Based Hair Fiber Extract to Gold, Keratin, and BMP-2. PLoS One (2015) 0.76
Molecular recognition of the antiretroviral drug abacavir: towards the development of a novel carbazole-based fluorosensor. J Fluoresc (2011) 0.75
Ionic derivatives of betulinic acid exhibit antiviral activity against herpes simplex virus type-2 (HSV-2), but not HIV-1 reverse transcriptase. Bioorg Med Chem Lett (2015) 0.75
Nutritional status of HIV-infected patients during the first year HAART in two West African cohorts. J Health Popul Nutr (2015) 0.75
Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J Acquir Immune Defic Syndr (2007) 4.30
Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature. J Acquir Immune Defic Syndr (2002) 3.55
Neuroglobin and cytoglobin. Fresh blood for the vertebrate globin family. EMBO Rep (2002) 2.50
Human serum albumin: from bench to bedside. Mol Aspects Med (2011) 2.46
Mutations in HIV-1 reverse transcriptase potentially associated with hypersusceptibility to nonnucleoside reverse-transcriptase inhibitors: effect on response to efavirenz-based therapy in an urban observational cohort. J Infect Dis (2004) 2.21
Estrogen signaling multiple pathways to impact gene transcription. Curr Genomics (2006) 2.14
Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol. Mol Biol Cell (2004) 2.07
The extraordinary ligand binding properties of human serum albumin. IUBMB Life (2005) 2.00
Massively parallel pyrosequencing highlights minority variants in the HIV-1 env quasispecies deriving from lymphomonocyte sub-populations. Retrovirology (2009) 1.99
Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: a systematic review. J Antimicrob Chemother (2007) 1.89
Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort. J Neurovirol (2005) 1.87
Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders. J Acquir Immune Defic Syndr (2009) 1.81
Human brain neuroglobin structure reveals a distinct mode of controlling oxygen affinity. Structure (2003) 1.75
Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART. AIDS Res Hum Retroviruses (2005) 1.52
Conformational and Coordination Equilibria on DOTA Complexes of Lanthanide Metal Ions in Aqueous Solution Studied by (1)H-NMR Spectroscopy. Inorg Chem (1997) 1.51
Variable prediction of antiretroviral treatment outcome by different systems for interpreting genotypic human immunodeficiency virus type 1 drug resistance. J Infect Dis (2003) 1.47
Common themes and variations in the rhodanese superfamily. IUBMB Life (2007) 1.46
Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure. AIDS Res Hum Retroviruses (2002) 1.45
Neuroactive antiretroviral drugs do not influence neurocognitive performance in less advanced HIV-infected patients responding to highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2006) 1.41
Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects. Mol Aspects Med (2009) 1.41
Multiple drug class-wide resistance associated with poorer survival after treatment failure in a cohort of HIV-infected patients. AIDS (2005) 1.37
Proteome analysis of human substantia nigra in Parkinson's disease. Proteomics (2004) 1.36
Hemoglobin and heme scavenging. IUBMB Life (2005) 1.34
A topological model of the interaction between alpha-synuclein and sodium dodecyl sulfate micelles. Biochemistry (2005) 1.33
Neurocognitive performance and quality of life in patients with HIV infection. AIDS Res Hum Retroviruses (2003) 1.29
Simultaneous determination of 16 anti-HIV drugs in human plasma by high-performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 1.21
Leishmania infantum leishmaniasis in corticosteroid--treated patients. BMC Infect Dis (2006) 1.19
AtCYS1, a cystatin from Arabidopsis thaliana, suppresses hypersensitive cell death. Eur J Biochem (2003) 1.16
Analysis of the periplasmic proteome of Pseudomonas aeruginosa, a metabolically versatile opportunistic pathogen. Proteomics (2009) 1.14
Crystal structure of cytoglobin: the fourth globin type discovered in man displays heme hexa-coordination. J Mol Biol (2004) 1.12
Heme-ligand tunneling in group I truncated hemoglobins. J Biol Chem (2004) 1.12
Transplacental transfer of antiretroviral drugs and newborn birth weight in HIV-infected pregnant women. Curr HIV Res (2009) 1.12
Allosteric modulation of drug binding to human serum albumin. Mini Rev Med Chem (2006) 1.11
Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment. J Antimicrob Chemother (2006) 1.11
S-palmitoylation modulates human estrogen receptor-alpha functions. Biochem Biophys Res Commun (2004) 1.10
Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz. BMC Infect Dis (2012) 1.10
Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study group. New Microbiol (2012) 1.10
S-palmitoylation modulates estrogen receptor alpha localization and functions. Steroids (2005) 1.09
Study of genotypic and phenotypic HIV-1 dynamics of integrase mutations during raltegravir treatment: a refined analysis by ultra-deep 454 pyrosequencing. J Infect Dis (2012) 1.09
An active-like structure in the unphosphorylated StyR response regulator suggests a phosphorylation- dependent allosteric activation mechanism. Structure (2005) 1.08
Relative prognostic value of self-reported adherence and plasma NNRTI/PI concentrations to predict virological rebound in patients initially responding to HAART. Antivir Ther (2004) 1.07
Varicella zoster virus infection presenting as isolated diplopia: a case report. BMC Infect Dis (2013) 1.04
A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz. J Acquir Immune Defic Syndr (2012) 1.04
Use of massive parallel pyrosequencing for near full-length characterization of a unique HIV Type 1 BF recombinant associated with a fatal primary infection. AIDS Res Hum Retroviruses (2009) 1.04
Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimens. J Acquir Immune Defic Syndr (2010) 1.03
Prevalence of pfcrt point mutations and level of chloroquine resistance in Plasmodium falciparum isolates from Africa. Infect Genet Evol (2005) 1.03
Eosinophilic meningitis in a returned traveler from Santo Domingo: case report and review. J Travel Med (2007) 1.02
Evaluating adherence to highly active antiretroviral therapy with use of pill counts and viral load measurement in the drug resources enhancement against AIDS and malnutrition program in Mozambique. Clin Infect Dis (2008) 1.01
Neuroprotective effects of 17β-estradiol rely on estrogen receptor membrane initiated signals. Front Physiol (2012) 1.01
Flavonoid binding to human serum albumin. Biochem Biophys Res Commun (2010) 1.01
Cyanide binding to truncated hemoglobins: a crystallographic and kinetic study. Biochemistry (2004) 1.00
Detection of quasispecies variants predicted to use CXCR4 by ultra-deep pyrosequencing during early HIV infection. AIDS (2011) 0.98
Immune reconstitution inflammatory syndrome associated with Mycobacterium tuberculosis infection: a systematic review. Int J Infect Dis (2009) 0.98
The pro-apoptotic effect of quercetin in cancer cell lines requires ERβ-dependent signals. J Cell Physiol (2012) 0.98
Styrene-catabolism regulation in Pseudomonas fluorescens ST: phosphorylation of StyR induces dimerization and cooperative DNA-binding. Biochem Biophys Res Commun (2003) 0.98
Drug-class-wide resistance to antiretrovirals in HIV-infected patients failing therapy: prevalence, risk factors and virological outcome. Antivir Ther (2006) 0.98
The R215W mutation in NBS1 impairs gamma-H2AX binding and affects DNA repair: molecular bases for the severe phenotype of 657del5/R215W Nijmegen breakage syndrome patients. Biochem Biophys Res Commun (2008) 0.98
Structural bases for heme binding and diatomic ligand recognition in truncated hemoglobins. J Inorg Biochem (2005) 0.97
Molecular bases for the anti-parasitic effect of NO (Review). Int J Mol Med (2002) 0.97
Neuroglobin and neuronal cell survival. Biochim Biophys Acta (2013) 0.97
Proteomics as a tool to improve investigation of substantial equivalence in genetically modified organisms: the case of a virus-resistant tomato. Proteomics (2004) 0.97
Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up. Vaccine (2009) 0.97
HIV-1 residual viremia and proviral DNA in patients with suppressed plasma viral load (<400 HIV-RNA cp/ml) during different antiretroviral regimens. Curr HIV Res (2008) 0.97
Membrane association of estrogen receptor alpha and beta influences 17beta-estradiol-mediated cancer cell proliferation. Steroids (2007) 0.97
Structural bases for substrate and inhibitor recognition by matrix metalloproteinases. Curr Med Chem (2008) 0.96
A TyrCD1/TrpG8 hydrogen bond network and a TyrB10TyrCD1 covalent link shape the heme distal site of Mycobacterium tuberculosis hemoglobin O. Proc Natl Acad Sci U S A (2003) 0.96
The preventive phase I trial with the HIV-1 Tat-based vaccine. Vaccine (2009) 0.95
Allostery in a monomeric protein: the case of human serum albumin. Biophys Chem (2010) 0.95
The therapeutic phase I trial of the recombinant native HIV-1 Tat protein. AIDS (2008) 0.95
The metalloproteolytic activity of the anthrax lethal factor is substrate-inhibited. J Biol Chem (2003) 0.94
Q151M-mediated multinucleoside resistance: prevalence, risk factors, and response to salvage therapy. Clin Infect Dis (2004) 0.94
Clinical and genotypic correlates of mutation K65R in HIV-infected patients failing regimens not including tenofovir. J Med Virol (2006) 0.94
Potential role of nonstatin cholesterol lowering agents. IUBMB Life (2011) 0.93
Dopaminergic therapies modulate the T-CELL proteome of patients with Parkinson's disease. IUBMB Life (2012) 0.93
Reactivity and endogenous modification by nitrite and hydrogen peroxide: does human neuroglobin act only as a scavenger? Biochem J (2007) 0.93
Use of darunavir/ritonavir once daily in treatment-naive pregnant woman: pharmacokinetics, compartmental exposure, efficacy and safety. AIDS (2010) 0.93
Ibuprofen induces an allosteric conformational transition in the heme complex of human serum albumin with significant effects on heme ligation. J Am Chem Soc (2008) 0.93
Involvement of Pseudomonas aeruginosa rhodanese in protection from cyanide toxicity. Appl Environ Microbiol (2006) 0.93
Inhibition of polyamine and spermine oxidases by polyamine analogues. FEBS J (2006) 0.92
Mapping protein matrix cavities in human cytoglobin through Xe atom binding. Biochem Biophys Res Commun (2004) 0.92
A novel mechanism of natural vitamin E tocotrienol activity: involvement of ERbeta signal transduction. Am J Physiol Endocrinol Metab (2009) 0.92
The C-terminal domain of the transcriptional corepressor CtBP is intrinsically unstructured. Protein Sci (2006) 0.92
Warfarin modulates the nitrite reductase activity of ferrous human serum heme-albumin. J Biol Inorg Chem (2013) 0.92
Monophyletic outbreak of Hepatitis A involving HIV-infected men who have sex with men, Rome, Italy 2008-2009. J Clin Virol (2012) 0.92
Reversible hexa- to penta-coordination of the heme Fe atom modulates ligand binding properties of neuroglobin and cytoglobin. IUBMB Life (2005) 0.91
Membrane-association determinants of the omega-amino acid monooxygenase PvdA, a pyoverdine biosynthetic enzyme from Pseudomonas aeruginosa. Microbiology (2008) 0.91
Interferon may prevent HIV viral rebound after HAART interruption in HIV patients. J Interferon Cytokine Res (2008) 0.91
Thr-E11 regulates O2 affinity in Cerebratulus lacteus mini-hemoglobin. J Biol Chem (2004) 0.91
Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure. J Infect Dis (2008) 0.91
Enzymatic detoxification of cyanide: clues from Pseudomonas aeruginosa Rhodanese. J Mol Microbiol Biotechnol (2008) 0.91
Dynamics of NRTI resistance mutations during therapy interruption. AIDS Res Hum Retroviruses (2009) 0.91